1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Univariate analysis for mFPE (TICI 2c–3)
Overall Patients ≥80 Years (n = 808)No mFPE (n = 458, 56.7%)mFPE (n = 350, 43.3%)P Value
Age (median) (IQR) (yr)85 (83–88)85 (83–88)85 (83–88.75).294
Female sex (No.) (%)521 (64.5)293 (56.2)228 (43.8).731
NIHSS score at admission (median) (IQR)17 (12–21)17 (12–21)17 (12–20).323
ASPECTS at admission (median) (IQR)9 (7–10)9 (7–10)9 (8–10).002
Last time seen well (median) (IQR) (min)280 (180.75–589.25)280 (183–608)280 (178–568.5).478
IV tPA administered (No.) (%)212 (26.2)125 (27.3)87 (24.9).459
General anesthesia (No.) (%)262 (32.4)138 (30.1)124 (35.4).123
Local anesthesia (No.) (%)160 (19.8)87 (19)73 (20.9)
Conscious sedation (No.) (%)386 (47.8)233 (50.9)153 (43.7)
Right-sided occlusion (No.) (%)388 (48)226 (49.3)162 (46.3).388
Level of vessel occlusion (No.) (%).564
 Carotid terminus157 (19.5)94 (20.6)63 (18)
 MCA-M1425 (52.7)234 (51.2)191 (54.6)
 MCA-M2225 (27.9)129 (28.2)96 (27.4)
GPTFR (median) (IQR) (min)7 (5–12)7 (5–13)7 (5–12).202
ET time (median) (IQR) (min)25 (12–43)37 (25–54.5)12 (8–20)<.001
GTR (median) (IQR) (min)35 (22–57)48 (35–71)22 (15–31)<.001
BGC use (No.) (%)465 (57.5)252 (55)213 (60.9).096
SR (No.) (%)790 (97.8)446 (97.4)344 (98.3).387
Combined technique use (CA + SR)406 (50.2)241 (52.6)165 (47.1).123
Distal aspiration catheter use (No.) (%)422 (52.2)251 (54.8)171 (48.9).094
Technique modification134 (27.9)130 (31.1)4 (6.3)<.001
sICH (No.) (%)53 (6.6)37 (8.1)16 (4.6).134
Complications.548
 Perforation11 (29.7)10 (33.3)1 (14.3)
 Dissection15 (40.5)12 (40)3 (42.9)
NIHSS score at 24 hr (median) (IQR)8 (3–16)12 (5–18)5 (2–12)<.001
mRS score 0–2 at 3 mo (No.) (%)303 (37.5)146 (31.9)157 (44.9)<.001
Mortality at 3 mo (No.) (%)225 (27.8)154 (33.6)71 (20.3)<.001
  • Note:—SR indicates stent retriever; CA, contact aspiration.